Dose-ranging study of mesalamine (PENTASA) enemas in the treatment of acute ulcerative proctosigmoiditis: results of a multicentered placebo-controlled trial. The U.S. PENTASA Enema Study Group.

Dose-ranging study of mesalamine (PENTASA) enemas in the treatment of acute ulcerative proctosigmoiditis: results of a multicentered placebo-controlled trial. The U.S. PENTASA Enema Study Group. Inflamm Bowel Dis. 1998 May; 4(2):79-83.

View in: PubMed

subject areas

Acute Disease
Adult
Analysis of Variance
Anti-Inflammatory Agents, Non-Steroidal
Colitis, Ulcerative
Colonoscopy
Dose-Response Relationship, Drug
Double-Blind Method
Enema
Female
Humans
Logistic Models
Male
Mesalamine
Middle Aged
Proctocolitis
Prospective Studies
Treatment Outcome

authors with profiles

Stephen B. Hanauer